Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil

被引：0
|
作者：
Lacerda, A. E. [1 ]
Piza, C. F. S. T. [2 ]
Marcelino, F. C. [3 ]
Camelo-Nunes, I. C. [1 ]
Ensina, L. F. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Sao Leopoldo Mand Med Sch, Campinas, Brazil
[3] HRAN Hosp Reg Asa Norte, Brasilia, DF, Brazil
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0555
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [1] Comparative safety of traditional non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors
    Bannwarth, B
    PRESSE MEDICALE, 2002, 31 (39): : 7 - 9
  • [2] COX-2 inhibitors: the next generation of non-steroidal anti-inflammatory drugs
    Schachna, L
    Ryan, PFJ
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (04) : 175 - 176
  • [3] COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease
    Ray, WA
    MacDonald, TM
    Solomon, DH
    Graham, DJ
    Avorn, J
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (01) : 67 - 70
  • [4] Cox-2 selective inhibitors, other non-steroidal anti-inflammatory drugs, and the risk of breast cancer
    Cronin-Fenton, Deirdre P.
    Pedersen, Lars
    Friis, Soren
    Lash, Timothy L.
    Baron, John A.
    Sorensen, Henrik Toft
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S10 - S11
  • [5] Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Galli, G
    Panzetta, G
    JOURNAL OF NEPHROLOGY, 2002, 15 (05) : 480 - 488
  • [6] First spontaneous reports of adverse reactions to the new selective COX-2 non-steroidal anti-inflammatory drugs
    Pedrós, C
    Cereza, G
    Laporte, JR
    MEDICINA CLINICA, 2002, 118 (11): : 415 - 417
  • [7] Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
    Ahmadi, Mohsen
    Bekeschus, Sander
    Weltmann, Klaus-Dieter
    von Woedtke, Thomas
    Wende, Kristian
    RSC MEDICINAL CHEMISTRY, 2022, 13 (05): : 471 - 496
  • [8] Risk of upper gastrointestinal complications with COX-2 inhibitors and non-steroidal anti-inflammatory drugs
    Castellsague, J.
    Holick, C. N.
    Hoffman, C. C.
    Stang, M. R.
    Lueck-Conteh, L.
    Perez-Gutthann, S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S83 - S83
  • [9] Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model
    Mullis, Brian H.
    Copland, Spencer T.
    Weinhold, Paul S.
    Miclau, Theodore
    Lester, Gayle E.
    Bos, Gary D.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2006, 37 (09): : 827 - 837
  • [10] First spontaneous reports of adverse drug reactions to the new selective COX-2 non-steroidal anti-inflammatory drugs
    Romero, AB
    Olivella, P
    MEDICINA CLINICA, 2002, 119 (13): : 516 - 517
12345